Keeping track of the SARS-CoV-2 vaccine pipeline.

Parker, Edward P K; Shrotri, Madhumita; Kampmann, Beate

Parker, Edward P K; Shrotri, Madhumita; Kampmann, Beate.

Parker EPK; The Vaccine Centre, London School of Hygiene & Tropical Medicine, London, UK. edward.parker@lshtm.ac.uk.
Shrotri M; The Vaccine Centre, London School of Hygiene & Tropical Medicine, London, UK.
Kampmann B; The Vaccine Centre, London School of Hygiene & Tropical Medicine, London, UK.

Nat Rev Immunol ; 20(11): 650, 2020 11.

Article in English | MEDLINE | ID: covidwho-808241

Subject(s)

Betacoronavirus/immunology; Coronavirus Infections/epidemiology; Coronavirus Infections/prevention & control; Pandemics/prevention & control; Pneumonia, Viral/epidemiology; Pneumonia, Viral/prevention & control; Viral Vaccines/biosynthesis; Betacoronavirus/drug effects; Betacoronavirus/pathogenicity; COVID-19; COVID-19 Vaccines; Clinical Trials as Topic; Coronavirus Infections/immunology; Coronavirus Infections/virology; Databases, Factual; Drug Approval; Humans; Immunogenicity, Vaccine; International Cooperation; Patient Safety; Pneumonia, Viral/immunology; Pneumonia, Viral/virology; SARS-CoV-2; Vaccination; Viral Vaccines/administration & dosage

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Viral Vaccines / Coronavirus Infections / Pandemics / Betacoronavirus Type of study: Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal: Nat Rev Immunol Journal subject: Allergy and Immunology Year: 2020 Document Type: Article Affiliation country: S41577-020-00455-1

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google